secwatch.observer — SEC 8-K summary
======================================

Issuer:     UTAH MEDICAL PRODUCTS INC (UTMD)
CIK:        0000706698
Form:       8-K
Filed at:   2022-02-02T23:59:59+00:00
Accession:  0001096906-22-000245
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01, 99.1
LLM model:  deepseek-v4-flash:cloud@v2

UTMD Q4 EPS $1.127; FY2021 sales $49.1M, net income up 37% YoY
--------------------------------------------------------------

- Diluted EPS Q4 $1.127 (up 20.6% YoY); FY GAAP EPS $4.041, non-GAAP $4.147.
- Full year revenue $49.1M (+16%); gross margin expanded to 63.0% from 60.6%.
- Operating income margin 38.5% vs 32.5%; adjusted EBITDA $26.5M (54.1% of sales).
- Paid $2.00/share special dividend in Dec 2021 ($7.3M) plus regular $0.285; cash $60.9M.
- Management projects 2022 adjusted EBITDA ~$30M, up from prior estimate of $28M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/706698/000109690622000245/0001096906-22-000245-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/706698/000109690622000245/utmd-20220201.htm
  HTML page:      https://secwatch.observer/filing/0001096906-22-000245

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer